DRI Healthcare Trust Announces Upsized US$500 Million Credit Facilities
Summary
The Facilities have a maturity date of October 31, 2026, and are secured by all of the assets of the Trust and most of its subsidiaries. "We are very pleased to see ongoing strong support from our syndicate of top-tier lenders and we are pleased to welcome The Toronto-Dominion Bank as our newest syndicate partner," stated Behzad Khosrowshahi, Chief Executive Officer of DRI Healthcare Trust. "Coupled with the funds secured from our recent follow-on offerings, this increased debt capacity will allow us to continue support innovation in the healthcare eco-system. Having deployed US$421 million in the past twelve months, we are well-positioned to execute on our robust US$3 billion pipeline of high-quality opportunities. Since our founding in 1989, DRI Capital has deployed more than US$2.5 billion, acquiring more than 70 royalties on 40-plus drugs, including Eylea, Keytruda, Orserdu, Spinraza, Stelara, Zejula and Zytiga.